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The persistence of antibody to hepatitis A antigen (anti-HAV) of the immu-
noglobulin M (IgM) class was evaluated in 88 sera of 51 acute hepatitis A patients.
IgM was separated from IgG by a 2-h reorienting sucrose gradient ultracentrifu-
gation, and the titer of anti-HAV was determined in the IgG- and IgM-containing
fractions by solid-phase radioimmunoassay. IgM anti-HAV was the predominat-
ing antibody at onset of jaundice and persisted in these patients for at least 60
days, but not longer than 115 days. The demonstration of IgM anti-HAV is
therefore a valuable tool for the diagnosis of recent hepatitis A infection.
Particles with an average diameter of 27 to 29
nm found in human stool specimens have been
shown to be the etiological agent of hepatitis A
infection (2). Recently, according to nucleic acid
and physical data, this virus could be classified
as a picornavirus (10, 11), as already suggested
by Provost and co-workers (8). Different meth-
ods such as radioimmunoassay (4, 9), immune
adherence (6), and complement fixation (7) have
been used to detect antibody to hepatitis A
antigen (anti-HAV). These antibodies can be
found by radioimmunoassay in all cases of hep-
atitis A after onset of jaundice, and absence of
anti-HAV at this stage of the disease excludes
hepatitis A (3). Because of the rapid increase in
antibody titer during the first 2 weeks of illness,
frequently no significant further increase in titer
can be found if the first serum is drawn late in
the course of the disease.
The presence of anti-HAV of the immuno-
globulin M (IgM) class (IgM anti-HAV) has
been shown in acute- and convalescent-phase
sera from human hepatitis A cases and from
experimentally infected chimpanzees by testing
of IgG- and IgM-containing serum fractions ob-
tained by molecular-sieve column chromatogra-
phy by radioimmunoassay (1). In serial serum
specimens from 10 patients, IgM anti-HAV was
separated from anti-HAV of the IgG class (IgG
anti-HAV) by sucrose gradient ultracentrifuga-
tion and determined by solid-phase radioimmu-
noassay (5). It was concluded that IgM anti-
HAV is present in acute hepatitis A in low titer,
but it may persist for almost 100 days after the
appearance of dark urine. Therefore, the dem-
onstration of IgM anti-HAV may serve as a
diagnostic marker for acute hepatitis A infection.
In this paper the persistence of IgM anti-HAV
is evaluated by using a less time-consuming re-
orienting sucrose gradient ultracentrifugation
method for the separation of IgG and IgM.
MATERIALS AND METHODS
Sera. Fifty-six sera were collected 0 to 200 days
after onset of jaundice from 19 patients during an
epidemic of hepatitis A in Gomaringen (4) and during
another outbreak in Neckartailfingen, Germany. In all
patients the diagnosis of hepatitis A was confirmed by
a more than fourfold increase in anti-HAV titer in a
solid-phase radioimmunoassay inhibition test (4).
Thirty-two additional sera were collected within 40
days after onset of jaundice from patients suspected
of having hepatitis A according to epidemiological and
clinical data.
Determination of IgM anti-HAV. IgM was sep-
arated from IgG by reorienting gradient centrifugation
(12), using a TV 865 rotor (DuPont Instruments, New-
ton, Conn.) and a Kontron centrifuge model TGA 50
(Zurich, Switzerland). A 50-,ul amount of serum was
layered on top of a 4-ml linear 5 to 35% (wt/wt)
preformed sucrose gradient in SABAG buffer (Teste-
rub, Rohm Pharma GmbH, Darmstadt, Germany) and
covered with 0.3 ml of mineral oil (Merck, Darmstadt,
Germany, no. 7174). After 2 h of centrifugation (50,000
rpm at 4°C), 12 to 13 fractions were collected from the
bottom of the tube. In each fraction the titer of anti-
HAV was determined by a solid-phase radioimmu-
noassay inhibition test, which has been described else-
where (4).
RESULTS
Figure 1 shows the typical results of a titration
of anti-HAV from the fractions of four sera
obtained from patient GBM which were col-
lected 0, 9, 57, and 193 days after onset of jaun-
dice. At day 0 (serum I) peak anti-HAV activity
was found in fractions 2 and 3. This corresponds
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FIG. 1. Reorienting sucrose gradient ultracentrifugation of four sera from patient GBM obtained at
different times after onset of hepatitis A. Anti-HAV titers determined by radioimmunoassay are given for all
serum fractions in addition to the concentrations of IgM and IgG from fractions of serum I. The relative
amounts of IgM anti-HAV were approximated by dividing the sum of the anti-HAV titers of fractions 1
through 4 by the sum of the titers of all fractions multiplied by 100 to equal the percent IgM anti-HAV of total
anti-HA V.
with the peak concentrations ofIgM determined
by radial immunodiffusion (Partigen, Behring-
werke AG, Marburg, Germany). Fractions 1, 4,
5, and 6 also showed low anti-HAV activity and
low IgM levels.
IgG was detected in fractions 5 through 12,
with peak concentrations in fractions 8, 9, and
10. In serum IV, collected 193 days after onset
of illness, the anti-HAV titers were closely par-
allel to the IgG concentrations. A low anti-HAV
titer was also found in fraction 4, which was
usually devoid of antibody activity whenever
lower- and medium-titered sera from patients
with past hepatitis A infections were tested.
Addition of an equal volume of 0.2 M mercap-
toethanol for 45 min at 370C reduced the anti-
body activity in fraction 2 more than eightfold
in serum I but did not change the antibody titer
in fraction 8 of serum IV. The data suggest that
antibody found in fractions 1, 2, and 3, and to
some extent in fraction 4, belongs to the IgM
class, whereas anti-HAV in fractions 5 through
12 is mainly of the IgG class. To obtain a rough
estimate of the percentage of IgM anti-HAV
present at different stages of the disease, the
antibody titers of fractions 1 through 4 were
added and expressed as a percentage of the sum
of the antibody titers of all fractions (Fig. 1,
Table 1).
At 0 to 5 days after onset of jaundice, between
29 and 100% (mean value, 54%) of the anti-HAV
TABLE 1. Persistence of anti-HAV of the IgM class
No. pOsitive % IgM Variation of
Days after on- for IgM anti- anoftoHtalV IgM anti-HAV
set of jaundice HAV/no. anti-HAV as % of total
testeant-HAV anti-HAV
VBtI (mean)
0-5 20/20 54 29-100
6-10 24/24 42 21-67
11-20 9/9 29 23-40
21-40 9/9 24 14-41
41-60 9/9 15 5-21
61-80 3/6 5 0-17
81-120 2/8 3 0-14
>120 0/3 0 0
present was of the IgM class (Table 1). The
percentage of IgM antibody decreased with time
after onset of jaundice. Between days 41 and 60,
5 to 21% anti-HAV was of the IgM class. Be-
tween days 61 and 120, only some of the sera,
and after 120 days no sera, were IgM anti-HAV
positive. The serum with the longest persistence
of IgM anti-HAV (115 days) was drawn from a
patient (SH) with elevation of serum transami-
nases for more than 3 months.
DISCUSSION
Frequently no significant increase in titer of
anti-HAV can be detected if the first serum is
drawn late in the course of hepatitis A. There-
fore, the demonstration of anti-HAV of the IgM
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class may be a valuable tool for the diagnosis of
a fresh hepatitis A infection.
IgM was separated from IgG by reorienting
gradient ultracentrifugation, and the titer of
anti-HAV was determined in the different frac-
tions. This method has considerable advantage
over conventional sucrose gradient centrifuga-
tion in swinging-bucket rotors. The procedure is
far less time consuming, due to the fact that
first, the centrifugation time is shorter (2 h in-
stead of 16 to 20 h) and, second, the rotor used
(TV 865) has a capacity of eight tubes as com-
pared to three to, maximally, six tubes in con-
ventional swinging-bucket rotors. As a conse-
quence, the running time is no longer a limiting
factor, and 16 to 24 samples can be set up, run,
and harvested per day using one centrifuge.
Moreover, the separation in this special fixed-
angle rotor is at least as good as in a long-column
swinging-bucket rotor. The determination of ti-
ters after separation of immunoglobulins by dif-
ferent sedimentation behavior is also a very sen-
sitive method, because no competition between
IgG and IgM antibody for the antigen takes
place, as may be found in IgM-specific radioim-
munoassay or in immunofluorescence methods.
One objection to this method is the possible
occurrence of false-positive results for IgM an-
tibody by IgG aggregates. However, this was not
observed in our study and can be controlled by
evaluating antibody titers with and without
treatment of the fractions with mercaptoetha-
nol.
According to this technique, at 0 to 5 days
after onset of jaundice more than half of the
total anti-HAV present belonged to the IgM
class, and it was found to persist for up to 60
days in every case. In sera collected between 60
and 100 days after onset of jaundice it was
present in the serum of part of the patients in
low titers. The patient in whom the longest
persistence of IgM anti-HAV was demonstrated
(115 days) also had elevated transaminases for
more than 3 months. It may be that IgM anti-
HAV persists somewhat longer in more severe
or prolonged cases of hepatitis A, but this needs
further study. Nevertheless, sera of all cases
obtained 120 days after onset of jaundice had
anti-HAV of the IgG class only, which makes
the demonstration of IgM anti-HAV a good
marker for the rapid diagnosis of a fresh hepa-
titis A infection from a single serum sample
drawn during the acute or convalescent stage of
the disease.
Reorienting sucrose gradient centrifugation
with subsequent testing of fractions for anti-
HAV is a very reliable and sensitive method for
the detection of specific antibody of the IgM
class. However, still less cumbersome methods
should be developed for routine testing of clini-
cal specimens.
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